American Airlines’ flight attendant union is expressing frustration over an upcoming change to the company’s healthcare plan, as flagged by PYOK. I’m curious to see how this plays out.
American angers union with 2026 healthcare changes
The Association of Professional Flight Attendants (APFA) isn’t happy about some changes that American is making to employee healthcare coverage for 2026. Specifically, this impacts members who rely on GLP-1 medications for their health.
Beginning January 1, 2026, the company’s health plan will only cover GLP-1 medications for individuals with type 2 diabetes. This means that unless flight attendants have diabetes, they will no longer be eligible to have drugs like Ozempic covered as part of the plan, even if considered to be medically necessary, and prescribed by a physician.
The union informed management that this raises serious concerns for members, and that reasonable alternatives are available to preserve member access to these medications, while addressing cost management.
For example, the union recommended implementation of copay caps to limit out-of-pocket exposure for members, use of prior authorization requirements to ensure medical necessity, and adoption of step therapy protocols.
Here’s what the union is claiming:
The company has chosen to bypass these alternatives and pursue outright exclusion for all employees, even with the growing recognition of obesity as a chronic disease.
This decision was made unilaterally by American Airlines. This change reduces the value of your healthcare coverage and strips treatment options Members rely on for prevention and quality of life. Your Union will continue to fight to have these medications covered for weight management.
We are urging all affected Members and those who stand in solidarity to contact company representatives directly. Voice your concerns about this decision. Share how this change impacts you, your family, or your ability to manage your health. Every message matters.
This is going to anger a lot of flight attendants
People of course have varying takes on drugs like Ozempic being used for weight loss. It does seem to be a “miracle” drug for weight loss, though I guess it remains to be seen if there are any long term health side effects (it’s beyond my area of expertise, of course, and I haven’t really looked much into Ozempic, other than what I’ve come across online).
One thing is for sure — Ozempic has made a huge difference in many peoples’ lives, though the retail cost is outrageously expensive, at around $1,000 per month. For most people that’s unaffordable, and for that matter, it sure seems like a medication shouldn’t cost five figures per year.
President Trump has been highlighting how he plans to lower the cost of Ozempic to $150 per month, but there’s no deal there yet, so it remains to be seen if that becomes a reality.
For those flight attendants who have found success with Ozempic, I certainly feel bad for them in the context of this coverage change. There’s a big health benefit to being a healthy weight, and if Ozempic is what helps people accomplish that, then it seems like a positive.
I also can’t say that I’m surprised to see American trying to cut costs with healthcare coverage. The company has very high labor costs, and is sort of struggling financially, as it’s significantly less profitable than Delta and United. The company has to find cost savings somewhere, and I guess this is the latest place it’s trying to do so.
Bottom line
As of 2026, American Airlines flight attendants will no longer have Ozempic covered as part of their healthcare plan, unless they have type 2 diabetes. The flight attendant union isn’t happy about this, given how many people rely on Ozempic for weight loss.
That certainly puts many flight attendants in a tough spot, given that the retail cost of Ozempic is around $1,000 per month.
What do you make of this American flight attendant healthcare coverage change?
